Divis Laboratories Share Price Today - Live Blog for April 11, 2025

Divis Laboratories Ltd witnessed a notable 0.16% surge in its share price and is presently trading at ₹5,598.05, captivating the attention of market participants.

The share price of Divis Laboratories Ltd has plummeted by -0.07%, signalling a challenging period. Currently trading at ₹5,586.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Divis Laboratories Ltd's stock has surged by 0.16%, and it is currently trading at ₹5,581.60. Additionally, the stock maintains a PE ratio of 69.1500, while the industry PE is 31.9023.

Divis Laboratories Ltd witnessed a notable 0.09% surge in its share price and is presently trading at ₹5,570.40, captivating the attention of market participants.

The stock of Divis Laboratories Ltd is making significant strides, boasting a 0.20% increase and currently trading at ₹5,556.05 per share. This upward trajectory is turning heads in the market.

Divis Laboratories Ltd's shares experienced a 0.20% uptick, and they are currently valued at ₹5,556.05, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0006 and an ROE of 13.3849%.

Investors are buzzing as Divis Laboratories Ltd's share price soared by an impressive 0.20%. At this moment, it's actively trading at ₹5,556.05, presenting an enticing opportunity for those in the market.

In the financial arena, Divis Laboratories Ltd's stock price has increased by 0.43%, with its current market value per share resting at ₹5,616.65. This development highlights the stock's appeal to investors.

The stock of Divis Laboratories Ltd is making significant strides, boasting a 0.43% increase and currently trading at ₹5,616.65 per share. This upward trajectory is turning heads in the market.

The stock of Divis Laboratories Ltd suffered a -0.19% drop, and it's now trading at ₹5,599.60 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Divis Laboratories Ltd witnessed a -0.12% decrease in its share price, and it is currently trading at ₹5,556.60. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 69.1500, an ROE of 13.3849% and a debt to equity ratio of 0.0006.

Divis Laboratories Ltd's share price has fallen by -0.12%, a situation worth noting. At present, the stock is trading at ₹5,556.60. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 69.1500, while the industry PE ratio is 31.9023.

Divis Laboratories Ltd's stock has surged by 0.67%, and it is currently trading at ₹5,555.05. Additionally, the stock maintains a PE ratio of 69.1500, while the industry PE is 31.9023.

The stock price of Divis Laboratories Ltd enjoyed a significant 0.27% boost, with the current market value at ₹5,524.80 per share. This surge has not gone unnoticed by investors.

Divis Laboratories Ltd observed a remarkable 0.39% surge in its share price and is presently trading at ₹5,514.70. The increased investor interest is driving this surge.

Divis Laboratories Ltd's shares saw an increase of 0.63%, reaching the current market price of ₹5,484.30. This development underscores the stock's growing popularity.

Investors are buzzing as Divis Laboratories Ltd's share price soared by an impressive 0.61%. At this moment, it's actively trading at ₹5,453.25, presenting an enticing opportunity for those in the market.

Divis Laboratories Ltd shares experienced a -0.87% reduction, with the current market price at ₹5,420.00. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Divis Laboratories Ltd experienced a -0.03% dip in its share price and is currently trading at ₹5,449.75. The stock has a PE ratio of 69.1500, an ROE of 13.3849% and a debt to equity ratio of 0.0006.

With a -3.61% decrease, Divis Laboratories Ltd's share price is currently at ₹5,446.30. This development raises questions about the factors behind the decline. The stock's PE ratio is 69.1500, while the industry PE is 31.9023.